Downloads: 80

Files in This Item:
File Description SizeFormat 
srep15666.pdf1.53 MBAdobe PDFView/Open
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInoue, Minoruja
dc.contributor.authorYoshimura, Michioja
dc.contributor.authorKobayashi, Minoruja
dc.contributor.authorMorinibu, Akiyoja
dc.contributor.authorItasaka, Satoshija
dc.contributor.authorHiraoka, Masahiroja
dc.contributor.authorHarada, Hiroshija
dc.contributor.alternative吉村, 通央ja
dc.contributor.alternative平岡, 眞寛ja
dc.contributor.alternative原田, 浩ja
dc.date.accessioned2016-05-12T06:33:12Z-
dc.date.available2016-05-12T06:33:12Z-
dc.date.issued2015-10-27ja
dc.identifier.issn2045-2322ja
dc.identifier.urihttp://hdl.handle.net/2433/210572-
dc.description.abstractThe cytotoxicity of ionizing radiation depends on the cell cycle phase; therefore, its pharmacological manipulation, especially the induction of cell cycle arrest at the radiosensitive mitotic-phase (M-phase), has been attempted for effective radiation therapy. Polo-like kinase 1 (PLK1) is a serine/threonine kinase that functions in mitotic progression, and is now recognized as a potential target for radiosensitization. We herein investigated whether PLK1 blockade enhanced the cytotoxic effects of radiation by modulating cell cycle phases of cancer cells using the novel small molecule inhibitor of PLK1, TAK-960. The TAK-960 treatment exhibited radiosensitizing effects in vitro, especially when it increased the proportion of M-phase cells. TAK-960 did not sensitize cancer cells to radiation when an insufficient amount of time was provided to induce mitotic arrest. The overexpression of a PLK1 mutant, PLK1-R136G&T210D, which was confirmed to cancel the TAK-960-mediated increase in the proportion of mitotic cells, abrogated the radiosensitizing effects of TAK-960. A tumor growth delay assay also demonstrated that the radiosensitizing effects of TAK-960 depended on an increase in the proportion of M-phase cells. These results provide a rational basis for targeting PLK1 for radiosensitization when considering the therapeutic time window for M-phase arrest as the best timing for radiation treatments.ja
dc.format.mimetypeapplication/pdfja
dc.language.isoengja
dc.publisherNature Publishing Groupja
dc.rightsThis work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ja
dc.titlePLK1 blockade enhances therapeutic effects of radiation by inducing cell cycle arrest at the mitotic phaseja
dc.type.niitypeJournal Articleja
dc.identifier.jtitleScientific Reportsja
dc.identifier.volume5ja
dc.relation.doi10.1038/srep15666ja
dc.textversionpublisherja
dc.identifier.artnum15666ja
Appears in Collections:Journal Articles

Show simple item record

Export to RefWorks


Export Format: 


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.